Data | Pre-implementation of VFA | Post implementation of VFA |
Dates | 1 September 2017 to 29 February 2020 | 1 March 2020 to 30 October 2022 |
Number of months | 30 | 30 |
Number of patients referred to FLS | 400 | 574 |
Number of FLS patients eligible for bone density testing | 366/400 (92%) | 460/574 (80%) |
Number of BMD scans undertaken at FLS imaging centre | ||
BMD normal | 70 | 64 |
BMD indicated osteoporosis | 118 | 139 |
BMD indicated osteopenia | 166 | 213 |
Total | 354/366 (97%) | 416/460 (90%) |
Number of BMD not undertaken | ||
BMD performed at another centre | 12 | 34 |
Patient declined | 0 | 8 |
Contraindicated | 0 | 2 |
Total | 12 | 44 |
Number of VFA performed at FLS imaging centre | ||
VFA normal | N/A | 220 |
VFA abnormal | N/A | 153 |
Total | 0 | 373 (90%) |
Number of VFA scans not undertaken at FLS imaging centre | ||
Patient unable to position for VFA | N/A | 27 |
Staff unable to carry out scan | N/A | 15 |
Patient declined | N/A | 1 |
Total | 0 | 43 (10%) |
Number of VFA performed at other facilities | ||
VFA normal | N/A | 1 |
VFA abnormal | N/A | 1 |
Total | 0 | 2 |
Normal BMD but abnormal VFA | N/A | 16/375 (4%) |
Osteopenia/osteoporosis diagnosis and abnormal VFA | N/A | 72 |
Number of treatment initiation started for osteopenia/osteoporosis (abnormal VFA)* | 159 | 170 (64) |
Number of treatment initiation started for normal BMD (abnormal VFA)* | 28 | 16 (8) |
Bone mineral density was measured through dual X-ray absorptiometry (DXA) scan. Total VFA is calculated using those who received DXA scan in the FLS imaging centre.
*Antiresorptive therapy.
BDT, bone densitometry team ; BMD, bone mineral density; CTF, Capture the Fracture ; FLS, Fragility Liaison Service; MDT, Multidisciplinary team ; SALHN, Southern Adelaide Local Health Network ; VFA, vertebral fracture assessment.